MIDDLETON, Mass., Nov. 6, 2025 /PRNewswire/ -- MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today ...
Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, today announced positive interim results from its ongoing POLARIS ...
To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...
Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...
Ultragenyx Pharmaceutical has dosed the first participant in Aurora, a study evaluating GTX-102 (apazunersen) for angelman syndrome (AS). The rare, neurogenetic condition results from the loss of ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has granted ...
Most parents hold their kids close. This mom dreams of seeing her daughter, born with a syndrome that severely limits her activities, ride away on her own.
SCOTTSDALE, Ariz. (InvestigateTV) — Patients are coming from around the world to Scottsdale to see the only neurosurgeon in the state performing a groundbreaking surgery that provides life-changing ...